ArticleInternational journal of hematology2026
Cost-effectiveness analysis of ropeginterferon alfa-2b for the management of patients with polycythemia vera in Japan.
Hiroki Yamaguchi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.